within Pharmacolibrary.Drugs.ATC.D;

model D11AH03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.03333333333333333,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00385,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cromoglicic acid, also known as cromolyn sodium, is a mast cell stabilizer used mainly for the prophylactic treatment of allergic conditions such as asthma, allergic rhinitis, and conjunctivitis. It is not a first-line therapy and its use has declined with the introduction of more effective medications, but it remains approved in several regions for specific indications.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetics in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li>R C Parish, L J Miller,Nedocromil sodium.,The Annals of pharmacotherapy,1993<a href='https://pubmed.ncbi.nlm.nih.gov/8394165/'>https://pubmed.ncbi.nlm.nih.gov/8394165/</a></li><li>C R Zeiss,Intense pharmacotherapy.,Chest,1992<a href='https://pubmed.ncbi.nlm.nih.gov/1591941/'>https://pubmed.ncbi.nlm.nih.gov/1591941/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D11AH03;
